Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Level 4 Department of Haematology Royal North Shore Hospital, Saint Leonard's

Westmead Hospital, Department of Haematology, Westmead

Peter MacCallum Cancer Institute, Melbourne

Mater Misericordiae Adult Hospital, South Brisbane

Oncology Haematology Radiation Oncology Unit, Princess Alexandra Hospital, Woolloongabba

Universitatskrankenhaus Eppendorf, Hamburg

Universitatsklinikum Essen, Essen

J.W. Goethe University Frankfurt, Frankfurt

Universitatsklinikum Mannheim, Mannheim

University of Texas, M.D. Anderson Cancer Center, Houston

University of Erlangen, Erlangen

Samara Regional Clinical Hospital, Samara

LKH Universitatsklinikum Graz, Graz

Allgemeines Krankenhaus der Stadt Wien, Vienna

Cross Cancer Centre, Edmonton

Hamilton Regional Cancer Center, Hamilton

Jewish General Hospital, Montreal

Universitatsklinikum Charite, Berlin

Blokhin Russian Cancer Research Center, RAMS, Moscow

Burdenko Main Military Clinical Hospital, Moscow

Central Research Institute of Skin and Venereal Diseases, Moscow

Haematology Research Center RAMS, Moscow

St. Petersburg Pavlov State Medical University, Saint Petersburg

Universitatsspital Zurich Dermatologische Klinik, Zurich

St. John's Institute of Dermatology, London

City Hospital, Nottingham

Southampton General Hospital, Southampton

Universitatsklinikum Munster, Münster

Medical Academy in Gdansk, Dept. of Hematology, Gdansk

Regional Oncological Center, Dept. of Chemotherapy, Lodz

Klinika Hematoonkologii Akademii Medycznej w Lublinie, Lublin

Oddzial Chorob Wewnetrznych i Hematologii, Poznan

The Medical University of Warsaw, Central Clinical Hospital, Warsaw

Centrum Onkologii-Instytut im. Marii Sklodoskiej-Curie, Warsaw